BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 24938203)

  • 1. Costs of pain in rheumatology.
    Marsico A; Atzeni F; Piroddi A; Cazzola M; Stisi S; Sarzi-Puttini P
    Reumatismo; 2014 Jun; 66(1):103-7. PubMed ID: 24938203
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Contribution of nurse-led clinics in the management of the patient with rheumatoid arthritis].
    de la Torre Aboki J
    Reumatol Clin; 2011 Mar; 6S3():S16-9. PubMed ID: 21794766
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic widespread pain in spondyloarthritis.
    Atzeni F; Boccassini L; Di Franco M; Alciati A; Marsico A; Cazzola M; Cassisi G; Sarzi-Puttini P
    Reumatismo; 2014 Jun; 66(1):28-32. PubMed ID: 24938193
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Large differences in cost of illness and wellbeing between patients with fibromyalgia, chronic low back pain, or ankylosing spondylitis.
    Boonen A; van den Heuvel R; van Tubergen A; Goossens M; Severens JL; van der Heijde D; van der Linden S
    Ann Rheum Dis; 2005 Mar; 64(3):396-402. PubMed ID: 15271773
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Biotechnological innovation to the benefit of the rheumatic patient].
    Minisola G
    Reumatismo; 2011 Nov; 63(3):125-8. PubMed ID: 22257913
    [No Abstract]   [Full Text] [Related]  

  • 6. The Corrona US registry of rheumatic and autoimmune diseases.
    Kremer JM
    Clin Exp Rheumatol; 2016; 34(5 Suppl 101):S96-S99. PubMed ID: 27762197
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pain in rheumatoid arthritis: a critical review.
    Sarzi-Puttini P; Salaffi F; Di Franco M; Bazzichi L; Cassisi G; Casale R; Cazzola M; Stisi S; Battellino M; Atzeni F
    Reumatismo; 2014 Jun; 66(1):18-27. PubMed ID: 24938192
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost of illness in rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis and systemic lupus erythematosus in Germany.
    Huscher D; Merkesdal S; Thiele K; Zeidler H; Schneider M; Zink A;
    Ann Rheum Dis; 2006 Sep; 65(9):1175-83. PubMed ID: 16540552
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Welfare as the goal of the analgesic pharmacotherapy accompanying biological treatment in patients with rheumatoid arthritis and ankylosing spondylitis].
    Tomasiewicz B; Hurkacz M; Jarzibowski J; Wiela-Hojeńska A
    Pol Merkur Lekarski; 2014 Nov; 37(221):274-9. PubMed ID: 25546988
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The pharmacoeconomics of newer therapeutics for rheumatic diseases.
    Kavanaugh A
    Rheum Dis Clin North Am; 2006 Feb; 32(1):45-56, viii. PubMed ID: 16504820
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rheumatoid arthritis.
    Sutor SM; Gricar JA; Cave DG
    Manag Care Interface; 1999 Jun; 12(6):51-3. PubMed ID: 10538460
    [No Abstract]   [Full Text] [Related]  

  • 12. [Medical and economic aspects of rheumatoid arthritis].
    Fautrel B; Gaujoux-Viala C
    Bull Acad Natl Med; 2012 Oct; 196(7):1295-305; discussion 1305-6. PubMed ID: 23815015
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost-utility analysis of duloxetine in osteoarthritis: a US private payer perspective.
    Wielage RC; Bansal M; Andrews JS; Klein RW; Happich M
    Appl Health Econ Health Policy; 2013 Jun; 11(3):219-36. PubMed ID: 23616247
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pain by name, pain by nature.
    Lipsky PE; Buckland J
    Nat Rev Rheumatol; 2010 Apr; 6(4):179-80. PubMed ID: 20357783
    [No Abstract]   [Full Text] [Related]  

  • 15. A review of duloxetine 60 mg once-daily dosing for the management of diabetic peripheral neuropathic pain, fibromyalgia, and chronic musculoskeletal pain due to chronic osteoarthritis pain and low back pain.
    Pergolizzi JV; Raffa RB; Taylor R; Rodriguez G; Nalamachu S; Langley P
    Pain Pract; 2013 Mar; 13(3):239-52. PubMed ID: 22716295
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Health-related quality of life and chronic pain experience in rheumatic diseases].
    Oliveira P; Monteiro P; Coutinho M; Salvador MJ; Costa ME; Malcata A
    Acta Reumatol Port; 2009; 34(3):511-9. PubMed ID: 19830929
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Should we switch from analgesics to the concept of "Pain Modifying Analgesic Drugs (PMADs)" in osteoarthritis and rheumatic chronic pain conditions?
    Perrot S
    Pain; 2009 Dec; 146(3):229-230. PubMed ID: 19695777
    [No Abstract]   [Full Text] [Related]  

  • 18. Fibromyalgia and arthritides.
    Atzeni F; Sallì S; Benucci M; Di Franco M; Alciati A; Sarzi-Puttini P
    Reumatismo; 2012 Sep; 64(4):286-92. PubMed ID: 23024973
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Somatoform disorders and rheumatic diseases: from DSM-IV to DSM-V.
    Alciati A; Atzeni F; Sgiarovello P; Sarzi-Puttini P
    Reumatismo; 2014 Jun; 66(1):98-102. PubMed ID: 24938202
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Primary care utilization among veterans with chronic musculoskeletal pain: a retrospective chart review.
    Beehler GP; Rodrigues AE; Mercurio-Riley D; Dunn AS
    Pain Med; 2013 Jul; 14(7):1021-31. PubMed ID: 23614929
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.